The evolution of functional assessments for spinal muscular atrophy (SMA) highlights the challenges of adapting pediatric ...

SMA Healthcare has announced an expansion at its new Marion County facility. The company is adding more than 45 residential ...

An infant with a fatal genetic disease has survived past the age of 2 with no signs of the condition, thanks to treatment ...

The XRP price dropped 3% in the last 24 hours as experts say consider this crypto wallet token that's charging toward $11 ...

The Reploy price plunged 11% in the past 24 hours as a crypto analyst says this AI Pepe hybrid might 20x after launch.

In his first month as Indian Bank's CEO, Binod Kumar aims to reshape the lender's credit focus amid concerns over personal ...

Ralph Lauren Corporation RL has been showing impressive upward momentum, trading above its 200-day and 50-day simple moving ...

The revolutionary drug, called risdiplam, was taken by the mother during her 32nd week of pregnancy and is now part of the ...

Researchers at the University of Pittsburgh say a new minimally invasive intervention can target the root cause of neural function loss.

The US Food and Drug Administration has approved a new drug application for a tablet version of Evrysdi (risdiplam) for people living with spinal muscular atrophy (SMA).

The Pound Sterling (GBP) hit its highest in over two months against the US Dollar (USD) as GBP/USD buyers remained ...

The EUR/USD pair fell throughout the first half of the week, recovering in the second half to close it little changed at ...